Innate Immune Signaling by Toll-like Receptor-4 (TLR4) Shapes the Inflammatory Microenvironment in Colitis-Associated Tumors

被引:126
|
作者
Fukata, Masayuki [1 ,2 ]
Hernandez, Yasmin [2 ]
Conduah, Daisy [2 ]
Cohen, Joson [2 ]
Chen, Anli [2 ]
Breglio, Keith [2 ]
Goo, Tyralee [2 ]
Hsu, David [2 ]
Xu, Ruliang [3 ]
Abreu, Maria T. [1 ,2 ]
机构
[1] Univ Miami, Miller Sch Med, Div Gastroenterol, Dept Med, Miami, FL 33101 USA
[2] Mt Sinai Sch Med, Dept Med, Div Gastroenterol, Ctr Inflammatory Bowel Dis, New York, NY USA
[3] Mt Sinai Sch Med, Dept Pathol, New York, NY USA
关键词
inflammation; colorectal cancer; mouse model; toll-like receptor; tumor microenvironment; NF-KAPPA-B; ULCERATIVE-COLITIS; COLORECTAL-CANCER; MICE LACKING; COLON-CANCER; EPITHELIAL PROLIFERATION; MACROPHAGE INFILTRATION; RISK-FACTOR; GROWTH; CARCINOGENESIS;
D O I
10.1002/ibd.20880
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Patients With ulcerative colitis are at increased risk for developing colorectal cancer. We have shown that Toll-like receptor-4 (TLR4) is overexpressed ill human colitis-associated cancer (CAC) and that nice deficient ill TLR4 are markedly protected against colitis-associated neoplasia. We wished to elucidate the specific contributions of TLR4 signaling by myeloid cells and colonic epithelial cells (CEC) in colitis-associated tumorigenesis. Methods: TLR4-deficient mice or wildtype littermates (WT) were transplanted with bone marrow (BM) cells: TLR4(-/-) BM -> WT mice (TLR4-expressing, CEC) and WT BM -> TLR4(-/-) mice (TLR4-expressing myeloid cells). Colitis-associated neoplasia was induced by azoxymethane (AOM 7.3 mg/kg) injection and 2 cycles of dextran sodium Sulfate (DSS) treatment. Results: The number and size of dysplastic lesions were greater in TLR4(-/-) BM -> WT mice than in WT BM -> TLR4(-/-) mice (P < 0.005). Histolopically, TLR4(-/-) BM -> WT mice had greater numbers of mucosal neutrophils and macrophages compared to WT BM -> TLR4(-/-) mice. The chemokines KC and CCL2, important in recruitment of macrophages and macrophages, respectively, were induced in mice expressing TLR4 it) CEC rather than the myeloid compartment. The lamina propria infiltrate of mice expressing TLR4 in CEC was characterized by macrophages expressing Cox-2. Moreover, mice expressing TLR4 in CEC rather than the myeloid compartment had increased production of amphiregulin and EGFR activation. Conclusions: These findings indicate that TLR4 signaling on CEC is necessary for recruitment and activation of Cox-2-expressing macrophages and increasing the number and size of dysplastic lesions. Our results implicate innate immune Signaling oil CEC as a key regulator of a tumor-promoting microenvironment. (Inflamm Bowel Dis 2009;15:997-1006)
引用
收藏
页码:997 / 1006
页数:10
相关论文
共 50 条
  • [1] Toll-like receptor-4 (TLR4) signaling induces a disintegrin and metalloproteinase (Adam)-17 and amphiregulin in colitis-associated neoplasia
    Fukata, Masayuki
    Ghiassi-nejad, Zahra
    Chen, Anli
    Breglio, Keith
    Goo, Tyralee
    Conduah, Daisy
    Subbaramaiah, Kotha
    Dannenberg, Andrew J.
    Abreu, Maria T.
    GASTROENTEROLOGY, 2007, 132 (04) : A424 - A424
  • [2] Toll-like receptor-4 (TLR4) is required for colitis-associated neoplasia in a murine model of inflammatory bowel disease (IBD)
    Fukata, Masayuki
    Chen, Anli
    Breglio, Keith
    Conduah, Daisy
    Goo, Tyralee
    Xu, Ruliang
    Dannenberg, Andrew
    Subbaramaiah, Kotha
    Cooper, Harry S.
    Abreu, Maria T.
    GASTROENTEROLOGY, 2007, 132 (04) : A39 - A39
  • [3] Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors
    Fukata, Masayuki
    Chen, Anli
    Vamadevan, Arunan S.
    Cohen, Jason
    Breglio, Keith
    Krishnareddy, Suneeta
    Hsu, David
    Xu, Ruiliang
    Harpaz, Noam
    Dannenberg, Andrew J.
    Subbaramaiah, Kotha
    Cooper, Harry S.
    Itzkowitz, Steven H.
    Abreu, Maria T.
    GASTROENTEROLOGY, 2007, 133 (06) : 1869 - 1881
  • [4] A Toll-Like Receptor 4 (TLR4) Antibody Antagonist Can Prevent Colitis-Associated Neoplasia
    Fukata, Masayuki
    Espana, Cecilia
    Ungaro, Ryan
    Sotolongo, John P.
    Pastorini, Cristhine
    Altman, Norman
    Zaias, Julia
    Vamadevan, Arunan S.
    Santaolalla, Rebeca
    Elson, Greg
    Kosco-Vilbois, Marie
    Hayes, Lory
    Abreu, Maria T.
    GASTROENTEROLOGY, 2010, 138 (05) : S445 - S445
  • [5] The role of prostaglandin E2 (PGE2) in toll-like receptor-4 (TLR4)-mediated colitis-associated neoplasia
    Hernandez, Yasmin
    Breglio, Keith J.
    Conduah, Daisy E.
    Chen, Anli
    Xu, Ruliang
    Hsu, David
    Ungaro, Ryan
    Abreu, Maria T.
    Fukata, Masayuki
    GASTROENTEROLOGY, 2008, 134 (04) : A242 - A242
  • [6] Toll-like receptor-4 (TLR4) expression in acute lung inflammation
    Janardhan, KSI
    McIsaac, M
    Fowlie, J
    Caldwell, S
    Singh, B
    FASEB JOURNAL, 2005, 19 (05): : A1536 - A1536
  • [7] Novel Role for the Innate Immune Receptor Toll-Like Receptor 4 (TLR4) in the Regulation of the Wnt Signaling Pathway and Photoreceptor Apoptosis
    Yi, Hyun
    Patel, Amit K.
    Sodhi, Chhinder P.
    Hackam, David J.
    Hackam, Abigail S.
    PLOS ONE, 2012, 7 (05):
  • [8] Toll-like receptor 4 (TLR4): new insight immune and aging
    Hyo-Jin Kim
    Hyemin Kim
    Jeong-Hyung Lee
    Cheol Hwangbo
    Immunity & Ageing, 20
  • [9] Toll-like receptor 4 (TLR4): new insight immune and aging
    Kim, Hyo-Jin
    Kim, Hyemin
    Lee, Jeong-Hyung
    Hwangbo, Cheol
    IMMUNITY & AGEING, 2023, 20 (01)
  • [10] Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists
    Peri, Francesco
    Piazza, Matteo
    BIOTECHNOLOGY ADVANCES, 2012, 30 (01) : 251 - 260